NCT01301066

A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects With Dyslipidemia, Followed by a 40-Week Safety Extension Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 252 (actual)
• Sponsor: Kowa Research Institute, Inc. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.

Conditions

• Dyslipidemia

Interventions

Type	Name	Description
DRUG	Pitavastatin	Pitavastatin 4 mg QD
DRUG	Pravastatin	Pravastatin 40 mg QD

Timeline

• Start date: 2010-12-01
• Primary completion: 2013-03-01
• Completion: 2013-03-01
• First posted: 2011-02-23
• Last updated: 2014-04-29
• Results posted: 2014-04-29

Locations

35 sites across 1 country: United States